ADORA2A and glaucoma: In addition, the α2-AR agonist, brimonidine, preserved visual function in glaucoma patients with low/normal IOP and high IOP, suggesting that pharmacological α2-AR activation may exert neuroprotective effects IOP independently [161,162,163].